With Watchman, Boston Scientific estimates a 20% compound annual growth rate (CAGR) in 2025 with a high market share. Mahoney ...
Boston Scientific closes the year at historic highs, with investors refusing to liquidate even at these levels. Check out why ...
Despite macroeconomic concerns, currency headwinds and related cost inflation, Boston Scientific Corporation BSX is seeing strength across target markets. The company is demonstrating growth backed by ...
In 2024, we saw another proactive year for some of the biggest names in medtech as they looked to bolster their ranks through ...
Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular ...